These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 23936492

  • 1. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
    Mutsaers HA, Engelke UF, Wilmer MJ, Wetzels JF, Wevers RA, van den Heuvel LP, Hoenderop JG, Masereeuw R.
    PLoS One; 2013; 8(8):e71199. PubMed ID: 23936492
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K, Shima H, Kikuchi K, Suzuki C, Suzuki T, Tomioka Y, Soga T, Ito S, Abe T.
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [Abstract] [Full Text] [Related]

  • 3. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
    Mutsaers HA, Caetano-Pinto P, Seegers AE, Dankers AC, van den Broek PH, Wetzels JF, van den Brand JA, van den Heuvel LP, Hoenderop JG, Wilmer MJ, Masereeuw R.
    Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
    [Abstract] [Full Text] [Related]

  • 4. Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.
    Snauwaert E, Van Biesen W, Raes A, Glorieux G, Van Bogaert V, Van Hoeck K, Coppens M, Roels S, Vande Walle J, Eloot S.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):978-986. PubMed ID: 28992139
    [Abstract] [Full Text] [Related]

  • 5. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J, Franczyk B, Ławiński J, Olszewski R, Ciałkowska-Rysz A, Gluba-Brzózka A.
    Toxins (Basel); 2021 Mar 31; 13(4):. PubMed ID: 33807343
    [Abstract] [Full Text] [Related]

  • 6. CE-MS-Based Identification of Uremic Solutes Specific to Hemodialysis Patients.
    Akiyama Y, Kikuchi K, Toyohara T, Mishima E, Suzuki C, Suzuki T, Nakayama M, Tomioka Y, Soga T, Abe T.
    Toxins (Basel); 2021 Apr 30; 13(5):. PubMed ID: 33946481
    [Abstract] [Full Text] [Related]

  • 7. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
    Zhang ZH, Mao JR, Chen H, Su W, Zhang Y, Zhang L, Chen DQ, Zhao YY, Vaziri ND.
    Clin Biochem; 2017 Dec 30; 50(18):1078-1086. PubMed ID: 28928007
    [Abstract] [Full Text] [Related]

  • 8. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Wulczyn KE, Shafi T, Anderson A, Rincon-Choles H, Clish CB, Denburg M, Feldman HI, He J, Hsu CY, Kelly T, Kimmel PL, Mehta R, Nelson RG, Ramachandran V, Ricardo A, Shah VO, Srivastava A, Xie D, Rhee EP, Kalim S, CRIC Study Investigators.
    Am J Kidney Dis; 2024 Jul 30; 84(1):49-61.e1. PubMed ID: 38266973
    [Abstract] [Full Text] [Related]

  • 9. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R, Mutsaers HA, Toyohara T, Abe T, Jhawar S, Sweet DH, Lowenstein J.
    Semin Nephrol; 2014 Mar 30; 34(2):191-208. PubMed ID: 24780473
    [Abstract] [Full Text] [Related]

  • 10. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W, Bush KT, Nigam SK.
    Sci Rep; 2017 Jul 10; 7(1):4939. PubMed ID: 28694431
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of uremic solutes in the cerebrospinal fluid in experimental acute renal failure.
    Mair RD, Nguyen H, Huang TT, Plummer NS, Sirich TL, Meyer TW.
    Am J Physiol Renal Physiol; 2019 Aug 01; 317(2):F296-F302. PubMed ID: 31141401
    [Abstract] [Full Text] [Related]

  • 12. An Enlarged Profile of Uremic Solutes.
    Tanaka H, Sirich TL, Plummer NS, Weaver DS, Meyer TW.
    PLoS One; 2015 Aug 01; 10(8):e0135657. PubMed ID: 26317986
    [Abstract] [Full Text] [Related]

  • 13. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F, Jankowski V, Gajjala PR, Zidek W, Jankowski J.
    ASAIO J; 2015 Aug 01; 61(1):55-60. PubMed ID: 25419832
    [Abstract] [Full Text] [Related]

  • 14. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.
    Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS.
    Kidney Int; 2014 May 01; 85(5):1214-24. PubMed ID: 24429397
    [Abstract] [Full Text] [Related]

  • 15. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL.
    Toxins (Basel); 2021 Feb 13; 13(2):. PubMed ID: 33668632
    [Abstract] [Full Text] [Related]

  • 16. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J, Jankowski J, Gajjala PR, Wetzels JFM, Masereeuw R.
    Clin Sci (Lond); 2017 Jul 15; 131(14):1631-1647. PubMed ID: 28667064
    [Abstract] [Full Text] [Related]

  • 17. Association of Plasma Uremic Solute Levels with Residual Kidney Function in Children on Peritoneal Dialysis.
    Ganesan LL, O'Brien FJ, Sirich TL, Plummer NS, Sheth R, Fajardo C, Brakeman P, Sutherland SM, Meyer TW.
    Clin J Am Soc Nephrol; 2021 Oct 15; 16(10):1531-1538. PubMed ID: 34233922
    [Abstract] [Full Text] [Related]

  • 18. Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration.
    Mutsaers HA, Wilmer MJ, Reijnders D, Jansen J, van den Broek PH, Forkink M, Schepers E, Glorieux G, Vanholder R, van den Heuvel LP, Hoenderop JG, Masereeuw R.
    Biochim Biophys Acta; 2013 Jan 15; 1832(1):142-50. PubMed ID: 23017367
    [Abstract] [Full Text] [Related]

  • 19. Critical Appraisal of Limitations in the Current Definition/Classification of Uremic Toxins.
    Husain-Syed F, Vanholder R, Rosner MH, Kawanishi H, Sirich TL, Ronco C.
    Blood Purif; 2023 Jan 15; 52(3):221-232. PubMed ID: 36513030
    [Abstract] [Full Text] [Related]

  • 20. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
    Mutsaers HA, van den Heuvel LP, Ringens LH, Dankers AC, Russel FG, Wetzels JF, Hoenderop JG, Masereeuw R.
    PLoS One; 2011 Apr 04; 6(4):e18438. PubMed ID: 21483698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.